• Dr. Mark Mamula | Advancing Canine Cancer Immunotherapy

  • Mar 5 2025
  • Length: 51 mins
  • Podcast

Dr. Mark Mamula | Advancing Canine Cancer Immunotherapy

  • Summary

  • In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Mark Mamula, an immunologist and professor at Yale University School of Medicine, to discuss his groundbreaking work in canine cancer immunotherapy. Dr. Mamula shares how his background in autoimmune diseases led him to develop an experimental vaccine targeting EGFR and HER2 proteins in dogs with cancer. He explains the science behind this therapy, its clinical trial progress, and its potential to improve survival outcomes for cancers such as osteosarcoma and hemangiosarcoma. They also explore the challenges of bringing new therapies to veterinary medicine, the role of combination treatments, and the importance of accessible, cost-effective options for pet owners. Tune in for an insightful conversation on the evolving landscape of canine cancer treatment and the promising future of immunotherapy.

    📝Transcripts are available at https://www.imprimedicine.com/podcast.

    To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/personalized-prediction-profile

    Music Credit: Hazy by Beat Mekanik

    Show more Show less
adbl_web_global_use_to_activate_webcro805_stickypopup

What listeners say about Dr. Mark Mamula | Advancing Canine Cancer Immunotherapy

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.